| Literature DB >> 34468884 |
Per S Strand1,2, Erik M Berntsen3,4, Even H Fyllingen3,4, Lisa M Sagberg5,6, Ingerid Reinertsen4,7, Sasha Gulati8,5, David Bouget7, Ole Solheim8,5.
Abstract
BACKGROUND: Prevalence, radiological characteristics, and risk factors for peritumoral infarctions after glioma surgery are not much studied. In this study, we assessed shape, volume, and prevalence of peritumoral infarctions and investigated possible associated factors.Entities:
Keywords: Diffusion-weighted imaging; Glioma; Infarction; Surgery
Mesh:
Year: 2021 PMID: 34468884 PMCID: PMC8520515 DOI: 10.1007/s00701-021-04914-z
Source DB: PubMed Journal: Acta Neurochir (Wien) ISSN: 0001-6268 Impact factor: 2.816
Fig. 1A Rim-shaped DWI change (volume = 2.7 cm3). B Sector-shaped DWI change (volume = 2.5 cm3). C A remote pontine DWI-change (volume = 0.2 cm3). D and E A sector-shaped and rim-shaped DWI change in the same brain (volume = 5.4 cm3). F A cavity without any significant DWI abnormality
Fig. 2A flowchart of the inclusion process
Characteristics of operations with vs. without peritumoral infarctions
| Table | Any infarction | No infarction | p value |
|---|---|---|---|
| Number of operations | 238 (44.2%) | 301 (55.8%) | |
| Tumor volume in cm3 (IQR) | 22.5 (8.5–49.8) | 24.99 (9.4–48.3) | 0.910 |
| Age in quartiles | |||
| 1: range (18–44) | 74 (51.4%) | 70 (48.6%) | 0.114 |
| 2: range (46–55) | 57 (45.2%) | 69 (54.8%) | |
| 3: range (56–64) | 60 (42.3%) | 82 (57.7%) | |
| 4: range (≥ 65) | 47 (37.0%) | 80 (63.0%) | |
| Sex | |||
| Female | 95 (44.4%) | 119 (55.6%) | 0.928 |
| Male | 143 (44.0%) | 182 (56.0%) | |
| Tumor entity | |||
| WHO grade 2 | 50 (48.1%) | 54 (51.9%) | 0.121 |
| WHO grade 3 | 50 (48.5%) | 53 (51.5%) | |
| WHO grade 4 | 132 (40.7%) | 192 (59.3%) | |
| Unspecified LGG | 3 (60.0%) | 2 (40%) | |
| Unspecified HGG | 3 (100%) | 0 (0.0%) | |
| LGG (WHO grade 2) | 53 (48.6%) | 56 (51.4%) | 0.293 |
| HGG (WHO grades 3–4) | 185 (43.0%) | 245 (56.0%) | |
| Tumor lateralization | |||
| Right | 120 (47.6%) | 132 (52.4%) | 0.312 |
| Left | 104 (40.9%) | 150 (59.1%) | |
| Bilateral/midline involvement | 14 (42.4%) | 19 (57.6%) | |
| Tumor distribution* | |||
| Frontal | 113 (40.5%) | 166 (59.5%) | 0.077 |
| Temporal | 102 (50.7%) | 99 (49.3%) | |
| Occipital | 23 (44.2%) | 29 (55.8%) | 0.991 |
| Parietal | 50 (39.4%) | 77 (60.6%) | 0.214 |
| Deep brain | 27 (39.1%) | 42 (60.9%) | 0.368 |
| Cerebellum | 3 (50.0%) | 3 (50%) | 0.772 |
| Brain stem | 1 (25.0%) | 3 (75.0%) | 0.439 |
| Intraventricular | 0(0.0%) | 1 (100%) | 0.382 |
| Operation | 0.513 | ||
| Primary surgery | 145 (45.3%) | 175 (54.7%) | |
| Reoperation | 93 (42.5%) | 126 (57.5%) | |
| Previous radiotherapy | 0.316 | ||
| Yes | 67 (47.9%) | 73 (52.1%) | |
| No | 171 (30.1%) | 398 (69.9%) | |
| Previous chemotherapy | 0.566 | ||
| Yes | 46 (46.0%) | 54 (54%) | |
| No | 192 (43.7%) | 247 (56.3%) | |
| Diabetes type 1 or 2 | 0.507 | ||
| Yes | 15 (50.0%) | 15 (50.0%) | |
| No | 223 (43.8%) | 286 (56.2%) | |
| Cerebrovascular disease | 0.222 | ||
| Yes | 12 (57.1%) | 9 (42.9%) | |
| No | 226 (43.6%) | 292 (56.4%) | |
| ASA grade | 0.542 | ||
| 1–2 | 174 (43.4%) | 227 (56.6%) | |
| 3–4 | 64 (46.4%) | 74 (53.6%) | |
| Preoperative KPS | 0.166 | ||
| ≥ 70 | 210 (45.3%) | 253 (54.6%) | |
| < 70 | 28 (36.8%) | 48 (63.2%) | |
| Surgeon | 0.298 | ||
| Resident | 34 (39.1%) | 53 (60.9%) | |
| Consultant | 204 (45.1%) | 248 (54.9%) | |
*If the tumor was in multiple lobes, it is registered in all affected lobes
Fig. 3From top: a brain model for reference, a heatmap with the distribution of tumors, and a heatmap with the distribution of all infarctions. Areas of interest are presented in percentages
Characteristics of operations with vs. without rim-shaped infarctions. Statistically significant values are highlighted
| Table | Rim only | No rim infarction | p value |
|---|---|---|---|
| Number of operations | 86 (16.0%) | 453 (84.0%) | |
| Tumor volume in cm3 (IQR) | 28.9 (9.3–49.3) | 22.5 (8.9–48.7) | 0.397 |
| Age in quartiles | |||
| 1: range (18–44) | 33 (22.9%) | 111 (77.1%) | |
| 2: range (45–55) | 22 (17.5%) | 104 (82.5%) | |
| 3: range (56–64) | 19 (13.4%) | 123 (86.6%) | |
| 4: range (≥ 65) | 12 (9.4%) | 115 (90.6%) | |
| Sex | |||
| Female | 38 (17.8%) | 176 (82.2%) | 0.354 |
| Male | 48 (14.8%) | 277 (85.2%) | |
| Tumor entity | |||
| WHO grade 2 | 20 (19.2%) | 84 (80.8%) | 0.545 |
| WHO grade 3 | 19 (18.4%) | 84 (81.6%) | |
| WHO grade 4 | 42 (13.0%) | 282 (87.0%) | |
| Unspecified LGG | 1 (20.0%) | 4 (80%) | |
| Unspecified HGG | 1 (33.3%) | 2 (67.7%) | |
| LGG (WHO grade 2) | 21 (19.3%) | 88 (80.7%) | 0.210 |
| HGG (WHO grades 3–4) | 62 (14.4%) | 368 (85.6%) | |
| Tumor lateralization | |||
| Right | 41 (16.3%) | 211 (83.7%) | 0.824 |
| Left | 41 (16.1%) | 213 (83.9%) | |
| Bilateral/midline involvement | 4 (12.1%) | 29 (87.9%) | |
| Tumor distribution* | |||
| Frontal | 43 (15.4%) | 236 (84.6%) | 0.721 |
| Temporal | 31 (15.4%) | 170 (84.6%) | 0.795 |
| Occipital | 5 (9.6%) | 47 (90.4%) | 0.189 |
| Parietal | 22 (17.3%) | 105 (82.7%) | 0.630 |
| Deep brain | 8 (11.6%) | 61 (88.4%) | 0.289 |
| Cerebellum | 0 (0.0%) | 6 (100%) | 0.283 |
| Brain stem | 0 (0.0%) | 4 (100%) | 0.382 |
| Intraventricular | 0(0.0%) | 1 (100%) | 0.681 |
| Operation | |||
| Primary surgery | 59 (18.4%) | 261 (81.6%) | 0.057 |
| Reoperation | 27 (12.3%) | 192 87.7%) | |
| Previous radiotherapy | |||
| Yes | 21 (15.0%) | 119 (85.0%) | 0.712 |
| No | 65 (16.3%) | 333 (83.7%) | |
| Previous chemotherapy | |||
| Yes | 12 (12.0%) | 88 (88.0%) | 0.666 |
| No | 74 (16.9%) | 365 (83.1%) | |
| Diabetes type 1 or 2 | 0.099 | ||
| Yes | 8 (26.7%) | 22 (73.3%) | |
| No | 78 (15.3%) | 431 (84.7%) | |
| Cerebrovascular disease | 0.412 | ||
| Yes | 2 (9.5%) | 19 (90.5%) | |
| No | 84 (16.2%) | 434 (83.8%) | |
| ASA grade | |||
| 1–2 | 66 (16.5%) | 335 (83.5%) | 0.586 |
| 3–4 | 20 (14.5%) | 118 (85.5%) | |
| Preoperative KPS | |||
| ≥ 70 | 10 (13.2%) | 66 (86.8%) | 0.472 |
| < 70 | 76 (16.4%) | 387 (83.6%) | |
| Surgeon | |||
| Resident | 13 (14.9%) | 74 (85.1%) | 0.778 |
| Consultant | 73 (16.2%) | 379 (83.8%) | |
Characteristics of operations with vs. without sector infarctions
| Table | Sector or rim + sector | No sector infarction | p value |
|---|---|---|---|
| Number of operations | 142 (26.3%) | 397 (73.7%) | |
| Tumor volume in cm3 (IQR) | 20.4 (8.2–1.7) | 25.4 (9.3–7.8) | 0.463 |
| Age in quartiles | |||
| 1: range (18–44) | 37 (25.7%) | 107 (74.3%) | 0.994 |
| 2: range (45–55) | 34 (27.0%) | 92 (73.0%) | |
| 3: range (56–64) | 38 (26.8%) | 104 (73.2%) | |
| 4: range (≥ 65) | 33 (26.0%) | 94 (74.0%) | |
| Sex | |||
| Female | 53 (24.8%) | 161 (75.2%) | 0.500 |
| Male | 87 (26.8%) | 238 (73.2%) | |
| Tumor entity | |||
| WHO grade 2 | 29 (27.9%) | 75 (72.1%) | 0.388 |
| WHO grade 3 | 31 (30.1%) | 72 (69.9%) | |
| WHO grade 4 | 79 (24.4%) | 245 (75.6%) | |
| Unspecified LGG | 1 (20.0%) | 4 (80%) | |
| Unspecified HGG | 2 (66.7%) | 1 (33.3%) | |
| LGG (WHO grade 2) | 30 (27.5%) | 79 (72.5%) | 0.754 |
| HGG (WHO grades 3–4) | 112 (26.0%) | 318 (74.0%) | |
| Tumor lateralization | |||
| Right | 74 (29.4%) | 178 (70.6%) | 0.328 |
| Left | 60 (23.6%) | 194 (76.4%) | |
| Bilateral/midline-involvement | 8 (24.2%) | 25 (75.8%) | |
| Tumor distribution* | |||
| Frontal | 65 (23.3%) | 214 (76.7%) | 0.096 |
| Temporal | 67 (33.3%) | 134 (66.7%) | |
| Occipital | 17 (32.7%) | 35 (67.3%) | 0.274 |
| Parietal | 27 (21.3%) | 100 (78.7%) | 0.137 |
| Basal ganglia | 17 (24.6%) | 52 (75.4%) | 0.730 |
| Cerebellum | 2 (33.3%) | 5 (66.7%) | 0.696 |
| Brain stem | 0 (0.0%) | 4 (100%) | 0.230 |
| Intraventricular | 0 (0.0%) | 1 (100%) | 0.542 |
| Operation | |||
| Primary surgery | 80 (25.0%) | 240 (75.0%) | 0.391 |
| Reoperation | 62 (28.3%) | 157 (71.7%) | |
| Previous radiotherapy | |||
| Yes | 44 (31.4%) | 96 (68.6%) | 0.116 |
| No | 98 (24.6%) | 300 (75.4%) | |
| Previous chemotherapy | |||
| Yes | 32 (32.0%) | 68 (68.0%) | 0.349 |
| No | 110 (25.1%) | 329 (74.9%) | |
| Diabetes type 1 or 2 | 0.700 | ||
| Yes | 7 (23.3%) | 23 (76.7%) | |
| No | 135 (26.5%) | 374 (73.5%) | |
| Cerebrovascular disease | 0.024 | ||
| Yes | 10 (47.6%) | 11 (52.4%) | |
| No | 132 (25.5%) | 386 (74.5%) | |
| ASA grade | |||
| 1–2 | 101 (25.2%) | 300 (74.8%) | 0.298 |
| 3–4 | 41 (29.7%) | 97 (70.3%) | |
| Preoperative KPS | |||
| ≥ 70 | 18 (23.7%) | 58 (76.3%) | 0.570 |
| < 70 | 124 (26.8%) | 339 (73.2%) | |
| Surgeon | |||
| Resident | 20 (23.0%) | 67 (77.0%) | 0.438 |
| Consultant | 122 (27.0%) | 330 (73.0%) | |